김상현 교수(의과대학 의학과)
o (2003) PhD,, University of Georgia, Athens, GA, USA
o (1997) MS., College of Pharmacy, Woosuk University, Korea
o (1995) BS., College of Pharmacy, Woosuk University, Korea
o (2020-2022) Director (PM), Division of Drug Discovery, National Research Foundation of Korea
o (2017-2019) Review Board (RB), National Research Foundation of Korea
o (2005- Present) Professor, Department of Pharmacology, School of Medicine, KNU, Daegu, Korea
o (2003-2004) Project Officer, National Toxicology Program, FDA, USA
o (2003-2004) Post-doctoral Fellow, Laboratory of Molecular Immunoregulation, NCI, NIH, Frederick, MD, USA
o Enhancement of efficacy of drug-nano carrier complex and defining of underlying mechanisms.
o Defining the molecular mechanisms of immune diseases focusing on the atopic dermatitis and hypersensitivity.
o Development of anti-allergic inflammatory drugs.
o Evaluation of the role of cold atmosphere plasma on immune diseases and drug delivery.
o Portable Cold Atmospheric Plasma Patch-Mediated Skin Anti-Inflammatory Therapy
o IRF3 Activation in Mast Cells Promotes FcεRI-Mediated Allergic Inflammation
o Pancreatic Tumor-Targeting Stemsome Therapeutics
o Complexity and multistability of a nonsmooth atopic dermatitis system
o Effect of the protein corona on nanoparticles for modulating cytotoxicity and immunotoxicity
In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This person’s work contributes towards the following SDG(s):